RELAPSED OR REFRACTORY PLASMA CELL NEOPLASMS
Clinical trials for RELAPSED OR REFRACTORY PLASMA CELL NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new RELAPSED OR REFRACTORY PLASMA CELL NEOPLASMS trials appear
Sign up with your email to follow new studies for RELAPSED OR REFRACTORY PLASMA CELL NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Double-barreled CAR-T takes aim at hard-to-treat blood cancers
Disease control Not yet recruitingThis early-phase study tests a new type of cell therapy that targets two markers (BCMA and CD70) on cancer cells. It is designed for people with high-risk plasma cell neoplasms, including multiple myeloma. The main goals are to check safety and find the right dose, while also mea…
Matched conditions: RELAPSED OR REFRACTORY PLASMA CELL NEOPLASMS
Phase: EARLY_PHASE1 • Sponsor: Affiliated Hospital to Academy of Military Medical Sciences • Aim: Disease control
Last updated May 17, 2026 10:40 UTC
-
Double-barreled cell therapy takes aim at hard-to-treat blood cancers
Disease control Not yet recruitingThis early-phase study tests a new treatment using a patient's own immune cells, engineered to attack two cancer targets (CD19 and BCMA), for people with certain blood cancers (like multiple myeloma or lymphoma) that have returned or stopped responding to standard therapy. About …
Matched conditions: RELAPSED OR REFRACTORY PLASMA CELL NEOPLASMS
Phase: EARLY_PHASE1 • Sponsor: Affiliated Hospital to Academy of Military Medical Sciences • Aim: Disease control
Last updated May 17, 2026 10:39 UTC
-
New dual-target CAR-T therapy takes on hard-to-treat blood cancers
Disease control Not yet recruitingThis early-phase study tests a new CAR-T cell therapy that targets two markers (CD70 and BCMA) on cancer cells. It is for people with plasma cell cancers like multiple myeloma that have come back or not responded to other treatments. The main goals are to check safety and find th…
Matched conditions: RELAPSED OR REFRACTORY PLASMA CELL NEOPLASMS
Phase: EARLY_PHASE1 • Sponsor: The General Hospital of Western Theater Command • Aim: Disease control
Last updated May 14, 2026 12:03 UTC